After Years Of Pushing HPV Vaccine As ‘Safe and Effective,’ CDC Now Taking A Closer Look
For the past 20 years, CDC vaccine advisers’ approach to HPV vaccination followed a trajectory of expanding eligibility, strengthening uptake and adding new indications. Now, the agency has convened a new workgroup to re-examine the vaccine from the ground up — its effectiveness, dosing, safety and long-term population impact.
TL;DR
- CDC vaccine advisers are re-examining the HPV vaccine.
- The workgroup will assess effectiveness, dosing, safety, and population impact.
- This follows 20 years of expanding HPV vaccine eligibility and uptake.